黑色素瘤患者研究优先事项:英国全国质性访谈研究
本研究在英国英格兰地区招募过去10年内确诊的黑色素瘤成人患者,通过半结构式访谈探讨患者认为重要的研究议题。20例患者访谈后归纳出五大主题:风险因素与预防、诊断延迟与误诊、治疗适应证与结局及副作用、随访优化、影响生存的因素。这是首项报告黑色素瘤患者研究优先事项的同行评议研究。
要点
- 患者优先关注可改变的危险因素及公共卫生预防策略研究。
- 患者希望研究支持非专科医生诊断并整合远程皮肤病学或人工智能以减少延迟。
- 患者重视新型治疗的适应证、结局、副作用及相互作用研究。
核心结论
- 首次报告黑色素瘤患者研究优先事项,识别出五大研究主题,部分与NICE研究建议一致并发现新主题。
研究设计与样本
- 质性访谈研究,在英国英格兰九个地区中的八个招募过去10年内确诊的黑色素瘤成人患者,共20例进行个体访谈。
- 采用扎根理论方法对转录文本进行迭代分析以识别主题。
主要发现
- 识别出五大主题:风险因素与预防、诊断延迟与误诊、治疗适应证与结局及副作用和相互作用、随访优化、影响生存的因素。
- 患者希望研究可改变的危险因素和公共预防宣传。
- 患者认为可通过支持非专科医生及整合远程皮肤病学或人工智能减少诊断延迟。
- 新型治疗激发患者希望研究治疗选择适应证、结局和副作用。
- 患者重视基于患者特异性因素准确预测复发和生存的研究。
关键数值与推荐
- 纳入标准为年龄≥18岁、过去10年内确诊黑色素瘤,通过皮肤癌慈善机构招募。
- 访谈前问卷收集人口学、肿瘤和治疗信息。
临床怎么用
- 研究结果可为研究者确定未来黑色素瘤研究重点提供依据,确保研究贴合患者需求。
- 所识别主题为建立James Lind Alliance优先事项设定伙伴关系提供理由。
局限性
- 样本仅来自英格兰,共20例,可能限制结果代表性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Outcomes for advanced melanoma have improved following the advent of immunotherapy and targeted therapy. This heralds a need for reconsideration of future research agendas. Patients can - and are keen to - help identify and prioritize research topics to ensure future research benefits patients. No previous peer-reviewed research has reported patient research priorities for melanoma. OBJECTIVES: To determine the prioritized research topics of patients with melanoma in England. METHODS: Patients aged ≥ 18 years, diagnosed with melanoma in the past 10 years, were recruited across England by skin cancer charities. Preinterview questionnaires obtained demographic, tumour and treatment information. Semi-structured interviews were conducted where patients were asked what they thought were important topics to research in melanoma. Using a grounded theory approach, transcripts were analysed in an iterative process to identify themes for patient research priorities. RESULTS: Twenty patients were individually interviewed from eight of nine English regions. Five key themes were identified: (1) 'Risk factors and prevention of melanoma' - patients voiced a desire for research into modifiable risk factors and public campaigns to prevent melanoma; (2) 'Diagnostic delay and misdiagnosis of melanoma' - patients felt diagnostic delays could be reduced through research to support nonspecialists and integrating technology such as teledermatology or artificial intelligence'; (3) 'Indications, outcomes, side-effects and interactions of treatments for melanoma' - novel treatments inspired patients to encourage future research into the indications, outcomes and side-effects of therapeutic options; (4) 'Optimizing follow-up for melanoma' - with increased survivorship, research to support the delivery of a personalized approach to follow-up was valued; and (5) 'Factors that influence survival from melanoma' - patients prioritized research to accurately predict recurrence and survival based on patient-specific factors. CONCLUSIONS: This is the first peer-reviewed study to report patient research priorities in melanoma. Many of the themes identified align with National Institute for Health and Care Excellence research recommendations. Additionally, novel themes were identified that provide a rationale to develop a James Lind Alliance Priority Setting Partnership for melanoma. If research addresses topics relevant to patients, decision-makers will be equipped to deliver services that meet patient needs. Melanoma is a type of skin cancer. It is relatively common and can have a huge impact on a person’s quality of life. In some cases, melanoma can result in death. Although there has been a lot of progress in developing new treatments, we do not know what people with melanoma think is most important to research. Therefore, we need to ask people what they think researchers should be looking at, so that we can make sure that future research benefit patients. This study was carried out in England. It aimed to find out what the important unanswered research priorities are of people with melanoma. To identify the research priorities, we interviewed 20 adults with melanoma. Patients provided insight into their experiences with melanoma and used these experiences to help us to identify future research priorities. We found five main areas that people with melanoma care about: understanding what causes melanoma, how to diagnose it, how to treat it, how to follow up with patients after treatment and how to improve survival rates. This was the first study to ask patients with melanoma what research they think is most important to them. These study findings could help researchers determine which topics should be focused on in the future, to make sure their work is useful to patients.
引用
- Mistry K, Srimudkul O, Patel M, et al. Patient research priorities in melanoma: a national qualitative interview study. Br J Dermatol. 2025. PMID: 40036376. doi:10.1093/bjd/ljaf048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。